Medicalsystem Biotechnology Co., Ltd (SHE:300439)

Market Cap	3.83B -12.6%
Revenue (ttm)	1.54B -5.7%
Net Income	66.57M -68.2%
EPS	0.17 -68.8%
Shares Out	384.32M
PE Ratio	58.98
Forward PE	n/a
Dividend	0.13 (1.35%)
Ex-Dividend Date	Jun 23, 2025

Volume	1,290,700
Average Volume	4,011,568
Open	9.98
Previous Close	9.97
Day's Range	9.97 - 10.12
52-Week Range	9.08 - 12.20
Beta	0.31
RSI	48.31
Earnings Date	Apr 29, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2003
• Employees: 2,104
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300439

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.